Indivior (INDV)

Sector: Pharma and Biotech     Index: FTSE 250
1.01%
3.30p
330.30p
17:18 23/10/17
330.30p
17:18 23/10/17
DAILY VARIATION
1.01%
3.30p
VOLUME
2,436,571
REAL TIME BATS
330.00p
17:36 23/10/17
1.20%
3.90p
DATA
52 Week High
n/a
52 Week Low
n/a
Shares Issued
721.46m
Market Cap
£2,382.99m
RiskGrade
n/a
Beta
n/a
MENU

Indivior Overview

Indivior is a pharmaceutical company specialising in addiction treatment. Indivior was spun out of parent Reckitt Benckiser in December 2014. Adding to its Suboxone opioid addiction product, the company has a pipeline including longer-lasting 'depot' formulations, treatments for cocaine intoxication, alcohol addiction and even schizophrenia, as a psychiatric co-morbidity of addiction.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 14.1% 34.3%
ROCE 75.6%
Latest F'cast
P/E 12.3 12.1
PEG 4.2 1.5
Pr/Revenue 2.9 2.8
Pr/Book -10.5
Latest F'cast
Revenue 4.3% 9.6%
PBT -65.6% n/a
EPS 2.9% 41.6%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
2014-12-31 1,115.00 561.00 58.00¢ 4.0 0.0 n/a n/a 0.0%
2015-12-31 1,014.00 285.00 34.00¢ 8.1 -0.2 -41% 12.70¢ 4.6%
2016-12-31 1,058.00 98.00 35.00¢ 10.4 3.5 3% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2017-12-31 832.36 285.48 28.45p 12.1 1.7 7% 0.00p 0.0%
2018-12-31 733.06 205.43 15.87p 15.1 -0.3 -44% 0.00p 0.0%

Regulatory News

slide to see more

Newspaper Links

No results found